Insider Shareholders with Direct Ownership of Laboratory Corp Of America Holdings (LH)
LH Quotes by TradingView
This section provides a comprehensive overview of the insiders with direct ownership of Laboratory Corp Of America Holdings (LH). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LABORATORY CORP OF AMERICA HOLDINGS Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
Adam H Schechter
President & CEO |
189,980 | 92,602 | 105,067 $24 Million | 37 |
Mar 27, 2025
Reduced 11.45%
|
Glenn A Eisenberg
Executive Vice President |
183,674 | 171,878 | 37,920 $8.65 Million | 56 |
Mar 27, 2025
Reduced 8.74%
|
Brian J Caveney
EVP, Pres of ED, CMO & CSO |
47,794 | 19,404 | 32,066 $7.31 Million | 46 |
Mar 27, 2025
Reduced 6.17%
|
Lance Berberian
EVP, Special Advisor, Strategy |
32,946 | 24,837 | 18,652 $4.25 Million | 39 |
Mar 27, 2025
Reduced 6.76%
|
Jean Luc Belingard
Director |
6,046 | 2,947 | 17,781 $4.05 Million | 10 |
Feb 07, 2024
Reduced 0.53%
|
Kerrii B Anderson
Director |
4,390 | 11,296 | 13,166 $3 Million | 15 |
Mar 05, 2025
Reduced 3.66%
|
Paul R Kirchgraber
CEO, Covance Drug Development |
30,851 | 25,992 | 12,946 $2.95 Million | 36 |
May 19, 2023
Reduced 24.93%
|
Peter M Neupert
Director |
7,890 | 0 | 12,887 $2.94 Million | 6 |
Feb 06, 2025
Added 6.83%
|
Garheng Kong
Director |
4,390 | 0 | 12,842 $2.93 Million | 5 |
Feb 06, 2025
Added 6.85%
|
Richelle P Parham
Director |
4,390 | 0 | 9,478 $2.16 Million | 5 |
Feb 06, 2025
Added 9.06%
|
Dwight Gary Gilliland
Director |
4,390 | 1,500 | 8,656 $1.97 Million | 7 |
Feb 06, 2025
Added 9.83%
|
R Sanders Williams
Director |
4,746 | 1,721 | 8,120 $1.85 Million | 7 |
Feb 07, 2024
Added 10.44%
|
Jonathan P. Di Vincenzo
EVP, Pres, Central Labs & Intl |
3,885 | 1,734 | 5,460 $1.25 Million | 11 |
Mar 27, 2024
Reduced 14.85%
|
Amy B. Summy
EVP, Chief Marketing Officer |
19,183 | 13,881 | 5,301 $1.21 Million | 39 |
Mar 28, 2025
Reduced 12.51%
|
Mark S Schroeder
EVP, Pres Diagnostics & COO |
50,699 | 49,377 | 4,960 $1.13 Million | 65 |
Mar 28, 2025
Reduced 34.69%
|
Jeffrey A. Davis
Director |
4,563 | 0 | 4,563 $1.04 Million | 6 |
Feb 06, 2025
Added 17.14%
|
Judith C Seltz
EVP, CHRO |
4,897 | 1,651 | 4,181 $953,435 | 14 |
Mar 30, 2023
Reduced 21.78%
|
Vaart Sandra D Van Der
EVP, Chief Legal Officer |
33,167 | 33,363 | 4,143 $944,769 | 60 |
Mar 27, 2025
Reduced 24.6%
|
Akinbolade Oyegunwa
EVP, CIO & CTO |
1,151 | 353 | 3,464 $789,930 | 8 |
Mar 27, 2025
Reduced 5.41%
|
Megan D. Bailey
EVP, Pres, Central Labs & Intl |
5,254 | 1,973 | 3,403 $776,020 | 10 |
Apr 01, 2025
Reduced 1.96%
|
Kathryn E Wengel
Director |
3,236 | 0 | 3,236 $737,937 | 4 |
Feb 06, 2025
Added 22.58%
|
Peter J Wilkinson
SVP, Chief Accounting Officer |
16,755 | 14,298 | 2,883 $657,439 | 48 |
Mar 27, 2025
Reduced 11.07%
|
Kirsten Marie Kliphouse
Director |
2,263 | 0 | 2,263 $516,054 | 3 |
Feb 06, 2025
Added 29.44%
|
Paul Rothman
Director |
1,661 | 0 | 1,674 $381,738 | 2 |
Feb 06, 2025
Added 36.06%
|
Anita Z Graham
EVP, CHRO |
1,064 | 344 | 750 $171,030 | 6 |
Feb 07, 2025
Reduced 13.69%
|
Julia Aijun Wang
Chief Financial Officer, EVP |
893 | 336 | 557 $127,018 | 2 |
Feb 06, 2025
Reduced 37.63%
|
Showing 1 to 26 of 26 entries